Kohn, D. B., Shaw, K. L., Garabedian, E., Carbonaro-Sarracino, D. A., Moore, T. B., De Oliveira, S., … Gaspar, H. B. (2019). Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. In JOURNAL OF CLINICAL IMMUNOLOGY (Vol. 39, pp. S44–S45).

Kohn, Donald B., Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino, Theodore B. Moore, Satiro De Oliveira, Gay M. Crooks, et al. “Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function.” In JOURNAL OF CLINICAL IMMUNOLOGY, 39:S44–45, 2019.

Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, et al. Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. In: JOURNAL OF CLINICAL IMMUNOLOGY. 2019. p. S44–5.

Kohn, Donald B., et al. “Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function.” JOURNAL OF CLINICAL IMMUNOLOGY, vol. 39, 2019, pp. S44–45.

Kohn DB, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Moore TB, De Oliveira S, Crooks GM, Tse J, Shupien S, Terrazas D, Davila A, Icreverzi A, Yu A, Barman PI, Coronel M, Fernandez BC, Zhang R, Hollis R, Uzowuru C, Ricketts H, Bayford JX, Trevisan V, Arduini S, Lynn F, Kudari M, Spezzi A, Reeves L, Cornetta K, Sokolic R, Parrott R, Buckley R, Booth C, Candotti F, Malech H, Thrasher AJ, Gaspar HB. Autologous ex vivo lentiviral gene therapy for the treatment of Severe Combined Immune Deficiency due to Adenosine Deaminase Deficiency (ADA-SCID) Improves B Cell Function. JOURNAL OF CLINICAL IMMUNOLOGY. 2019. p. S44–S45.